Instead of gambling on which pharmaceutical company will develop the next COVID vaccine/test, invest in the "shovel sellers" - companies providing essential equipment and software to pharma R&D. Veeva Systems (VEEV) is highlighted as a prime example, offering specialized CRM and clinical trial management software with high barriers to entry, strong financials, and surging usage during the pandemic.